ClinicalTrials.gg
RecruitingNCT07358741Updated Jan 22, 2026

Standard Two-Day Advanced Life Support (ALS) Versus One Day Recertification Course

An observational study in Skill Performance and Knowledge, sponsored by National Hepatology & Tropical Medicine Research Institute. Recruiting at 1 site in Egypt. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-01-22.

Sponsored by National Hepatology & Tropical Medicine Research Institute · Observational

From the registry’s dates

  • Primary completion was expected by Jun 2026, 4 months ago, but the record still lists the study as recruiting.
  • Started Dec 2025; still recruiting 11 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
158
Ages
18 Years and older
Sex
All
01

Study summary

this study aims to compare the effectiveness of a one-day versus two-day ALS recertification course in terms of knowledge retention, practical skills performance, participant satisfaction, and confidence.

Read the detailed description

demographic data will be collected, including participants' age, sex, specialty, prior ALS course completion, participation in resuscitation teams, last CPR performance, and total online learning hours (minimum 16 hours for the standard ALS course and 8 hours for the recertification course). All ALS courses (standard and recertification) will be conducted in accordance with the standardized curriculum, structure, and educational formats established by the European Resuscitation Council (ERC).

Assessments:

A. Knowledge Assessment B. Practical Skills Performance C. Participant satisfaction and confidence at the end of each course

  • Scoring: 0 = Not performed/incorrect, 1 = Partially/performed with prompting, 2 = Performed correctly and independently.
02

Conditions studied

  • Skill Performance
  • Knowledge

Keywords

  • Standard
  • recertification
  • ALS
  • ERC
  • knowledge retention
03

In context

Lead sponsor

National Hepatology & Tropical Medicine Research Institute is the lead sponsor of 20 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

demographic data will be collected, including participants' age, sex, specialty, prior ALS course completion, participation in resuscitation teams, last CPR performance, and total online learning hours (minimum 16 hours for the standard ALS course and 8 hours for the recertification course).

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult healthcare professionals (≥18 years) requiring ALS recertification, including doctors, nurses, and paramedics, who can attend the assigned course and follow-up assessments.

Exclusion criteria

Exclusion Criteria:

  • Participants will be excluded if they cannot attend the assigned course or decline consent.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
158 participants (estimated)
Target follow-up
90 Days
Patient registry
Yes

Groups and cohorts

  • standard ALS course

    Two day course

  • Recertification Course

    one day course

06

What researchers measure

Primary outcomes

  1. overall effectiveness between the two-day stanrdand one-day ALS recertification

    • Baseline knowledge score

    Time frame: 24hours precourse

  2. Practical skill effectiveness

    • Standardized team-leader assessment station at the end of each course. Scoring: 0 = Not performed/incorrect, 1 = Partially/performed with prompting, 2 = Performed correctly and independently.

    Time frame: 48 and 24 hours from standard amd recertification course respectively

  3. Knowledge retention assessment

    post-course MCQ to evaluate decay; similar to pre-course MCQ

    Time frame: 3 months post course

Secondary outcomes

  1. Participant satisfaction e

    scores about course structure, teaching quality, and learning materials; 1: Strongly disagree- 2:disagree- 3: moderate 4: agree- 5: Strongly agree

    Time frame: 48hours and 24 from standard and recertification course respectively

07

Study locations

1 of 1 sites recruiting
  • Egyptian resuscitation council
    Cairo, Egypt
    Recruiting
08

References and documents

Individual participant data

Plan to share: No — The individual participant data (IPD) generated in this study will not be made publicly available in order to protect participant confidentiality and comply with ethical regulations.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Dec 2025 (actual). Primary completion is estimated for Jun 2026, 6 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 9, 2025
First posted
Jan 22, 2026
StartActual
Dec 12, 2025
Primary completionEst.
Jun 30, 2026
CompletionEst.
Nov 30, 2026
Last update
Jan 22, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 22, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07358741
Lead sponsor
National Hepatology & Tropical Medicine Research Institute
Responsible party
ICU (Associate professor-intensive care medicine, National Hepatology & Tropical Medicine Research Institute) — Principal investigator
First posted
Jan 22, 2026
Start date
Dec 12, 2025
Primary completion
Jun 30, 2026 (estimated)
Completion
Nov 30, 2026 (estimated)
Last update
Jan 22, 2026

Study contacts

Eman Ibrahim El-Desoki Mahmoud, MD, intensive care medicine
Contact
eman18350@gmail.com
+2 01227409501

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion